Recent reports have indicated that deacetylation of FOXO-1 by SIRT1 could enhance VEGF-C transcription in the nuclei of prostate cancer cells and facilitate the growth of endothelial cells in mice [13, 25]. This evidence concerns the gene VEGFC and prostate cancer.